Related Experiment Video
Updated: Jul 17, 2026

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Large pleural effusions occurring after coronary artery bypass grafting. Cardiovascular Surgery Associates, PC
R W Light1, J T Rogers, D Cheng
1Pulmonary Disease Program, Saint Thomas Hospital and Vanderbilt University, Nashville, Tennessee 37202, USA. RLIGHT98@yahoo.com
Insights
Large pleural effusions after coronary artery bypass grafting (CABG) occur in less than 1% of patients. Many effusions are unexplained, with bloody types often manageable by thoracentesis.
Area of Science:
- Cardiology
- Thoracic Surgery
- Pulmonology
Background:
- Large pleural effusions are an infrequent complication following coronary artery bypass grafting (CABG).
- The clinical course and characteristics of these effusions are not well-understood.
Purpose of the Study:
- To characterize the clinical course and pleural fluid findings in patients experiencing large pleural effusions post-CABG.
Main Methods:
- Retrospective case series analysis of 3707 patients undergoing CABG.
- Review of chest radiographs and medical records for effusion characteristics, treatment, and outcomes.
- Analysis of pleural fluid findings, including cytology and biochemistry.
Main Results:
- 29 patients (0.78%) developed large pleural effusions ( >25% hemithorax).
- Causes included congestive heart failure (7), pericarditis (2), and pulmonary embolism (1); 19 were unexplained.
- Bloody effusions (8) were typically left-sided, occurred earlier, and had higher LDH; nonbloody effusions (11) were more challenging to manage.
Conclusions:
- Large pleural effusions are a rare post-CABG complication with often unclear etiology.
- Bloody effusions generally respond to therapeutic thoracentesis.
- Nonbloody effusions may necessitate anti-inflammatory agents, chest tube placement, or sclerotherapy.
Background:
Large pleural effusions sometimes occur after coronary artery bypass grafting (CABG), but their characteristics and clinical course are largely unknown.
Objective:
To describe the clinical course and pleural fluid findings in patients with large pleural effusions occurring after CABG.
Design:
Retrospective case series.
Setting:
Tertiary care, university-affiliated, nonprofit teaching hospital.
Patients:
3707 patients who had CABG between 1 February 1996 and 1 August 1997.
Measurements:
Chest radiographs were reviewed, and information on pleural fluid findings, pleural effusion treatment, and cardiac surgery was obtained from medical records and a cardiac surgery database.
Results:
Pleural effusions that occupied more than 25% of the hemithorax were found in 29 patients (0.78%). Seven of the effusions were attributed to congestive heart failure, 2 were attributed to pericarditis, and 1 was attributed to pulmonary embolism. The explanation for the remaining 19 effusions was unclear. All but 2 effusions were predominantly left-sided. Of these 19 effusions, 8 were bloody and 11 were nonbloody. Bloody effusions usually occurred earlier, contained higher lactic acid dehydrogenase levels, and were frequently eosinophilic. Nonbloody effusions tended to be more difficult to manage.
Conclusions:
Large pleural effusions may develop in a small proportion of patients after CABG. The cause of many of these effusions is unclear. Most bloody effusions can be managed with one to three therapeutic thoracenteses. Resolution of nonbloody effusions may require anti-inflammatory agents, tube thoracostomy, or intrapleural injection of sclerosing agents.
Related Concept Videos
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pneumothorax-II
Clinical Manifestations:
Pericarditis II: Clinical Features and Diagnostic Tests
Pericarditis III: Medical Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

